Literature DB >> 7848274

Isoform I (mdr3) is the major form of P-glycoprotein expressed in mouse brain capillaries. Evidence for cross-reactivity of antibody C219 with an unrelated protein.

L Jetté1, J F Pouliot, G F Murphy, R Béliveau.   

Abstract

P-glycoprotein (P-gp) is expressed in various non-cancerous tissues such as the endothelial cells of the blood-brain barrier. We used several monoclonal antibodies (mAbs) and isoform-specific polyclonal antibodies to establish which P-gp isoforms are expressed in isolated mouse brain capillaries. P-gp class I isoform was detected in capillaries with a Western immunoblotting procedure using a specific antiserum. No immunoreactivity was observed with either class II- or class III-specific antisera. Immunoreactivity was observed with mAb C219. However, this antibody detected two distinct immunoreactive proteins (155 and 190 kDa) in the isolated brain capillaries. These two proteins comigrated as a broad band when the samples were submitted to heat prior to gel electrophoresis. The glycoprotein nature of these two antigens was evaluated by their sensitivity to N-glycanase treatment. Following this treatment, the size of the proteins was reduced from 190 and 155 kDa to 180 and 120 kDa, respectively. Triton X-114 phase-partitioning studies showed that the 190 kDa immunoreactive protein was poorly solubilized by Triton X-114, while the 155 kDa protein was partitioned in the detergent-rich phase. In labelling experiments, only the 155 kDa protein was photolabelled with [125I]iodoarylazidoprazosin. These results show that a 190 kDa protein detected by antibody C219 is an antigen unrelated to the three P-gp isoforms presently known. Cross-reactivity of C219 with an unrelated protein emphasizes the fact that more than one antibody should be used in the assessment of P-gp expression in cell lines and tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7848274      PMCID: PMC1136324          DOI: 10.1042/bj3050761

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins.

Authors:  P Gros; J Croop; D Housman
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

3.  Reduced permeability in CHO cells as a mechanism of resistance to colchicine.

Authors:  V Ling; L H Thompson
Journal:  J Cell Physiol       Date:  1974-02       Impact factor: 6.384

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Recent advances in understanding brain capillary function.

Authors:  G W Goldstein; A L Betz
Journal:  Ann Neurol       Date:  1983-10       Impact factor: 10.422

Review 6.  Biochemistry of multidrug resistance mediated by the multidrug transporter.

Authors:  M M Gottesman; I Pastan
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

7.  endo-beta-N-acetylglucosaminidase F: endoglycosidase from Flavobacterium meningosepticum that cleaves both high-mannose and complex glycoproteins.

Authors:  J H Elder; S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

8.  High levels of P-glycoprotein detected in isolated brain capillaries.

Authors:  L Jetté; B Têtu; R Béliveau
Journal:  Biochim Biophys Acta       Date:  1993-08-15

9.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

10.  Electrophoretic analysis of P-glycoproteins produced by mouse J774.2 and Chinese hamster ovary multidrug-resistant cells.

Authors:  L M Greenberger; S S Williams; E Georges; V Ling; S B Horwitz
Journal:  J Natl Cancer Inst       Date:  1988-06-01       Impact factor: 13.506

View more
  8 in total

Review 1.  The impact of efflux transporters in the brain on the development of drugs for CNS disorders.

Authors:  Eve M Taylor
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

3.  P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain.

Authors:  E Beaulieu; M Demeule; L Ghitescu; R Béliveau
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

4.  Antibody C219 recognizes an alpha-helical epitope on P-glycoprotein.

Authors:  J M van Den Elsen; D A Kuntz; F J Hoedemaeker; D R Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits.

Authors:  R G del Moral; M Andujar; C Ramírez; M Gómez-Morales; M Masseroli; M Aguilar; A Olmo; F Arrebola; M Guillén; M J García-Chicano; F F Nogales; F O'Valle
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

Review 6.  Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain.

Authors:  P L Golden; W M Pardridge
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

7.  P-glycoprotein Expression Is Upregulated in a Pre-Clinical Model of Traumatic Brain Injury.

Authors:  Sydney M Vita; John B Redell; Mark E Maynard; Jing Zhao; Raymond J Grill; Pramod K Dash; Bernadette E Grayson
Journal:  Neurotrauma Rep       Date:  2020-11-18

Review 8.  The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.

Authors:  Lavanya Varatharajan; Sarah A Thomas
Journal:  Antiviral Res       Date:  2009-01-25       Impact factor: 5.970

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.